# A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors

> **NCT02115165** · PHASE2 · COMPLETED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 34 (actual)

## Conditions studied

- Non-seminomatous Germ-cell Tumors

## Interventions

- **DRUG:** Cabazitaxel

## Key facts

- **NCT ID:** NCT02115165
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-23
- **Primary completion:** 2022-04-29
- **Final completion:** 2023-04-24
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02115165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02115165, "A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02115165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*